The pharmaceutical and biotech industries are under constant pressure to deliver new therapies faster, more efficiently, and at lower costs. Contract Research Organizations (CROs) have become essential partners in achieving these goals by providing specialized expertise, advanced technologies, and flexible service models.

At ARSI Canada, we work as an extension of our clients’ teams, helping them overcome challenges in discovery and development. From custom synthesis and analytical support to regulatory-driven studies, our services are designed to reduce risk, shorten timelines, and ensure scientific precision — giving innovators the confidence to move forward in a competitive market.

Moving from laboratory-scale experiments to larger production quantities is one of the most critical transitions in the drug development process. Poorly managed scale-up can result in delays, higher costs, or inconsistent results — challenges that can stall innovation.

With our custom scale-up services, ARSI Canada bridges the gap between milligram-scale research and gram-to-kilo quantities. Our team ensures reproducibility, efficiency, and regulatory compliance at every step. By optimizing this process, we help researchers move from proof-of-concept to clinical and commercial readiness with speed and confidence.

Every successful therapy relies on accurate, validated, and regulatory-compliant testing methods. Analytical method development is more than a technical step; it’s the foundation of reliable results that safeguard patient safety and support regulatory approval.

At ARSI Canada, we specialize in chromatography, spectroscopy, and method validation tailored to each client’s project. Our commitment to precision and compliance ensures that every dataset is robust, reproducible, and trusted by regulators worldwide. By partnering with us, companies gain not only reliable analytics but also peace of mind throughout their development journey.

Drug stability is one of the most critical aspects of pharmaceutical development. Understanding how a drug substance or product reacts under stress conditions provides valuable insights into its shelf life, safety, and regulatory compliance. Forced degradation studies are designed to accelerate these processes, identifying potential degradation pathways and ensuring long-term quality.

At ARSI Canada, we conduct comprehensive forced degradation studies aligned with ICH guidelines. Our team uses advanced analytical techniques to detect impurities, evaluate stability, and ensure that products meet stringent industry requirements. By identifying risks early, we help clients design robust formulations, avoid costly setbacks, and bring safe, effective therapies to market with confidence.